Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. . Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant hydrochloride, is a new weight loss drug, not only can lose weight, but also lower blood pressure, cholesterol and blood sugar. …

Rimonabant (Acomplia) was the first in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1). Acomplia was studied for use in the treatment of obesity and related conditions. An experimental wonder drug, Rimonabant, helps you lose weight, quit smoking and it also helps protect your heart. Trials have shown that 33% of people on Rimonabant lost 10% of …